Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Recruiting 4Active not recruiting 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Other hematologic neoplasm 1Breast 1

Conditions

Motor Activity 3Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Hematologic Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 641pembrolizumab 585Magnetic Resonance Spectroscopy 555Carboplatin 431Cyclophosphamide 381Cisplatin 379Biopsy 376Nivolumab 315Paclitaxel 314Gemcitabine 308Radiotherapy 286Bevacizumab 235Dexamethasone 218fludarabine 206Docetaxel 194durvalumab 189Oxaliplatin 189venetoclax 187Rituximab 175Fluorouracil 175atezolizumab 172Pemetrexed 167Capecitabine 164Radiosurgery 162Doxorubicin 162Radiation 160Ipilimumab 146Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Nutritional Status × 90 days × Clear all
NCT06872515 2026-05-26

Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

University of Pittsburgh

Phase NA Recruiting
20 enrolled
Gastrointestinal

Esophageal Neoplasms, Motor Activity

NCT05912257 2026-05-20

NOSH

VA Office of Research and Development

Phase NA Recruiting
188 enrolled
Tumor-Agnostic

Neoplasms

NCT07467824 2026-04-16

PREACT

European University Miguel de Cervantes

Phase NA Recruiting
66 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT06712797 2026-03-13

PANTHER-PIC

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Active not recruiting
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07173166 2026-03-10

CARE-T

Instituto de Investigacion Sanitaria INCLIVA

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Motor Activity, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡